bioMD Limited ABN: 35 088 221 078
Copyright Disclaimer Privacy Policy
Corporate Governance
Corporate Governance disclosure Back
 
The Board and management are committed to corporate governance and to the extent they are applicable to the Company have adopted the Ten Essential Corporate Governance Principles and each of the Best Practice Recommendations as published by ASX Corporate Governance Council. To read the Ten Essential Corporate Governance Principles and each of the Best Practice Recommendations click here. BCDocs;151316;1
 
During the Reporting Period the Company has complied with each of the Ten Essential Corporate Governance Principles and the corresponding Best Practice Recommendations, other than in relation to the matters specified below. A copy of the Best Practice Recommendations1 are set out on this website. Note do not disclose table on website until Annual Report is lodged with ASX2.
 
Principle Ref
Recommendation Ref
Notification of Departure
Explanation for Departure
2
2.1
No member of the board satisfies the test of independence as set out in box 2.1 of ASX Corporate Governance Council Practice ("Independence Test").
The board considers Mr Scott to be independent for the reasons set out under the heading "Identification ofIndependent Directors" on page [ ] of the Annual Report.  The Company's focus is on development of a suite of medical products. The head office is a corporate office only. The Company is currently at a stage too early in the development process to warrant additions to the Board fo directors. The current board structure comprises an Independent Chairman, Managing Director and Executive Director. At present the board considers this structure best suits the Company's present activities.
 
2.2
The Chairperson does not satisfy paragraph 3 of the Independence Test
Notwithstanding this, the board considers Mr Scott to be independent for the reasons set out under the heading "Identification of Independent Directors" see page [ ] of the Annual Report.
 
2.4
There is no formal Nomination Committee
The whole board carries out the duties of a nomination committee. In so acting the whole boardfollows the nomination committee charter, disclosed on the Company's Website.
3
3.2
The Company adopted a written securities trading policy on [insert date].
Although prior to [insert date] there was no written policy, there was an understanding as to when it was appropriate for security trading to occur which understanding is the basis upon which the written policy is adopted.
4
4.3
The Audit Committee comprises one member only, Mr Scott who is also the chairman of the Company.
The duties carried out by an audit committee are performed by Mr Scott who has relevant financial and industry experience to qualify him to perform this role. He carries out audit committee review of both half yearly and annual financial results.
 
1 A copy of the Best Practice Recommendations are set out on this website. BCDocs;151316;1
2 Note do not disclose table on website until Annual Report is lodged with ASX